Latest News
For more information regarding each of the news items below click on the Headline for the full news article.
|
New product 4CYTE' Equine ready to launch in Australia
Interpath will be launching its new product 4CYTE' Equine to the Australia market in June.
|
| |
|
Australian research company Interpath achieves highest International recognition for new generation Sashas EQ.
The future has arrived! That was
the overwhelming response at the
conclusion of Dr Wendy Pearson's
presentation at the recent British
Equine Veterinarian Association
Conference (BEVA) in Liverpool,
England. Dr Pearson presented
results from a major four year
research project funded by
Interpath. The project discovered a
new botanical joint health -active-
and developed an all new joint
health product for horses called
Sashas EQ.
|
| |
|
Interpath join forces with Petplan insurance
For over 30 years Petplan has been the worlds leading pet insurance provider recommended by more pet owners and industry professionals than any other. Interpath are delighted to have formed an alliance with Petplan pet insurers.
|
| |
|
Follow the Joint Degeneration Process
Interpath have designed userfriendly diagrams to explain what happens within the joint during the degeneration process
|
| |
|
Interpath R&D Released!!!
Interpath research has been released on Anti-inflammatory and chondroprotective effects of nutraceuticals from Sasha's Blend in a cartilage explant model of inflammation with fantastic results.....
|
| |
|
Vet Nurses Conference 2007
As one of Provets largest
suppliers of veterinary products
Interpath was invited to be part
of their promotion at the recent
Vet Nurses Conference in Perth.
|
| |
|